Skip to main content

Table 2 Survival analysis for cases of mucinous carcinoma and high-grade serous carcinoma

From: Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis

 

Progression-free survival

Overall survival

 

Univariate analysis

Multivariate analysis

Univariate analysis

Multivariate analysis

Variables

HR (95% CI)

p-value

HR (95% CI)

p-value

HR (95% CI)

p-value

HR (95% CI)

p-value

Age (years)

            

≥60 vs. <60

1.25

(0.92–1.70)

0.16

   

1.20

(0.83–1.73)

0.32

   

FIGO stage

            

I vs. II, III, IV

0.18

(0.09–0.30)

<0.01

0.19

(0.08–0.39)

<0.01

0.10

(0.04–0.22)

<0.01

0.08

(0.03–0.22)

<0.01

Residual tumor at PDS

            

Yes vs. No

2.40

(1.70–3.44)

<0.01

1.11

(0.76–1.68)

0.60

2.65

(1.75–4.12)

<0.01

1.05

(0.67–1.70)

0.84

Histological subtype

            

MC vs. HGSC

0.40

(0.23–0.65)

<0.01

1.05

(0.57–1.80)

0.87

0.45

(0.24–0.78)

<0.01

1.54

(0.78–2.79)

0.20

  1. Abbreviations
  2. HR, hazard ratio; CI, confidence interval; FIGO, International Federation of Obstetrics and Gynecology; PDS, primary debulking surgery; MC, mucinous carcinoma; HGSC, high-grade serous carcinoma